CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $127,032 | -2.4% | 4,616 | +20.3% | 0.01% | 0.0% |
Q2 2023 | $130,189 | +2.6% | 3,837 | +8.9% | 0.01% | 0.0% |
Q1 2023 | $126,830 | -22.8% | 3,525 | 0.0% | 0.01% | -28.6% |
Q4 2022 | $164,230 | +65.9% | 3,525 | 0.0% | 0.01% | +75.0% |
Q3 2022 | $99,000 | +4.2% | 3,525 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $95,000 | -20.8% | 3,525 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $120,000 | -11.8% | 3,525 | 0.0% | 0.00% | -20.0% |
Q4 2021 | $136,000 | -28.4% | 3,525 | 0.0% | 0.01% | -28.6% |
Q3 2021 | $190,000 | +84.5% | 3,525 | +14.7% | 0.01% | +75.0% |
Q2 2021 | $103,000 | – | 3,074 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |